DIRAIMONDO THOMAS (Chief Scientific Officer) sold 2.0% of their position (2.50K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $34.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/2/2026ACC: 0002005618-26-000002
Officer· Chief Scientific Officer
Since Jan 2024
+138.79K
Net shares
Net buyer
$34.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
141.30K acquired · 2.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.50K
Price / share
$13.73
Trade value
$34.39K
% of position
2.0%
1/2/2026
126.93K→124.42K
Common Stock
Direct
Shares
+31.40K
Price / share
—
Trade value
—
% of position
25.2%
1/2/2026
124.42K→155.82K
Total
Net shares
+28.89K
Net value
-$34.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −2.50K | $13.73 | $34.39K | 2.0% | 126.93K | 124.42K |
| Common Stock Direct | 1/2/2026 | A · Award | +31.40K | — | — | 25.2% | 124.42K | 155.82K |
| Total | +28.89K | -$34.39K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
109.90K shares
Shares
+109.90K
Strike price
13.65
Held after
109.90K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock109.90K shares | 1/2/2026 | A · Award | +109.90K | 13.65 | — | 109.90K |